Journal of Cancer Therapy

Vol.9 No.11(2018), Paper ID 88518, 16 pages

DOI:10.4236/jct.2018.911073

 

Efficacy of Nilotinib versus Imatinib in Philadelphia Positive Patients with Chronic Myeloid Leukemia in Early Chronic Phase Who Have a Warning Molecular Response to Imatinib

 

Amen Hamdy Zaky Aly, Ahmed EL Sayed Mohammed Khalifa, Esraa Abdallah Abdelkariem Gadallah

 

Department of Medical Oncology, South Egypt Cancer Institute, Assuit University, Assiut, Egypt
Department of Clinical Oncology, Faculty of Medicine, Sohag University, Sohag, Egypt
Department of Medical Oncology, Sohag Cancer Center, Sohag, Egypt

 

Copyright © 2018 Amen Hamdy Zaky Aly, Ahmed EL Sayed Mohammed Khalifa, Esraa Abdallah Abdelkariem Gadallah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Aly, A. , Khalifa, A. and Gadallah, E. (2018) Efficacy of Nilotinib versus Imatinib in Philadelphia Positive Patients with Chronic Myeloid Leukemia in Early Chronic Phase Who Have a Warning Molecular Response to Imatinib. Journal of Cancer Therapy, 9, 883-897. doi: 10.4236/jct.2018.911073.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.